会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • Polyethylene Aerogel and Method of Production
    • 聚乙烯气凝胶及其生产方法
    • US20150247016A1
    • 2015-09-03
    • US14700387
    • 2015-04-30
    • Yosry A. Attia
    • Yosry A. Attia
    • C08J9/00
    • C08J9/00C08J9/28C08J9/33C08J2201/0482C08J2201/0524C08J2205/026C08J2323/04C08J2323/06C08J2323/08
    • A method for making polyethylene aerogels, including high molecular weight aerogels, commences by in a hydrocarbon solvent (e.g., toluene or benzene) in which polyethylene is insoluble at room temperature, adding polyethylene to the solvent heated to a temperature at which said polyethylene is soluble to form a reaction mixture. A free-radical catalyst is added to the reaction mixture and the reaction mixture is held until the desired gelation of the polyethylene has been achieved. The reaction mixture is cooled to about room temperature; and the hydrocarbon solvent is replaced with a gas (e.g., CO2 or air) to form the polyethylene aerogel. Optionally, the cooled reaction mixture can be contacted with an anti-solvent for polyethylene to replace the hydrocarbon solvent with the anti-solvent. Silica aerogel particles can be encapsulated in polyethylene aerogel by adding the particles to the polyethylene gelation reaction mixture.
    • 制造聚乙烯气凝胶的方法,包括高分子量气凝胶,在烃溶剂(如甲苯或苯)中开始,其中聚乙烯在室温下不溶解,加入聚乙烯加热到所述聚乙烯可溶的温度 以形成反应混合物。 向反应混合物中加入自由基催化剂,并保持反应混合物,直至达到所需的聚乙烯凝胶化。 将反应混合物冷却至约室温; 并且用气体(例如CO 2或空气)代替烃溶剂以形成聚乙烯气凝胶。 任选地,冷却的反应混合物可与用于聚乙烯的反溶剂接触以用抗溶剂代替烃溶剂。 通过将颗粒加入到聚乙烯凝胶化反应混合物中,可以将二氧化硅气凝胶颗粒包封在聚乙烯气凝胶中。
    • 9. 发明授权
    • Medical devices and applications of polyhydroxyalkanoate polymers
    • 聚羟基链烷酸酯聚合物的医疗装置和应用
    • US06838493B2
    • 2005-01-04
    • US10082954
    • 2002-02-26
    • Simon F. WilliamsDavid P. MartinFrank A. Skraly
    • Simon F. WilliamsDavid P. MartinFrank A. Skraly
    • A61B17/58A61F2/84A61K45/00A61L15/64A61L17/00A61L17/12A61L27/00A61L27/18A61L27/58A61L31/06A61L31/14C08G63/06C08K5/00C12P7/62C08L67/04A61F13/00
    • A61L27/58A61F2/07A61F2210/0004A61K31/715A61L17/12A61L27/18A61L31/06A61L31/148A61L31/16A61L2300/00C08G63/06C08J9/26C08J2201/0444C08J2201/0482C08J2367/04C08K5/0033C08L67/04C12P7/625Y10S606/911
    • Devices formed of or including biocompatible polyhydroxyalkanoates are provided with controlled degradation rates, preferably less than one year under physiological conditions. Preferred devices include sutures, suture fasteners, meniscus repair devices, rivets, tacks, staples, screws (including interference screws), bone plates and bone plating systems, surgical mesh, repair patches, slings, cardiovascular patches, orthopedic pins (including bone filling augmentation material), adhesion barriers, stents, guided tissue repair/regeneration devices, articular cartilage repair devices, nerve guides, tendon repair devices, atrial septal defect repair devices, pericardial patches, bulking and filling agents, vein valves, bone marrow scaffolds, meniscus regeneration devices, ligament and tendon grafts, ocular cell implants, spinal fusion cages, skin substitutes, dural substitutes, bone graft substitutes, bone dowels, wound dressings, and hemostats. The polyhydroxyalkanoates can contain additives, be formed of mixtures of monomers or include pendant groups or modifications in their backbones, or can be chemically modified, all to alter the degradation rates. The polyhydroxyalkanoate compositions also provide favorable mechanical properties, biocompatibility, and degradation times within desirable time frames under physiological conditions.
    • 由生物相容性聚羟基链烷酸酯形成或包括生物相容性聚羟基链烷酸酯的设备具有受控的降解速率,优选在生理条件下小于一年。 优选的装置包括缝线,缝线紧固件,弯液面修复装置,铆钉,钉,钉,螺钉(包括干涉螺钉),骨板和骨电镀系统,外科手术网,修复贴片,吊索,心血管贴片,矫形针 材料),粘附屏障,支架,引导组织修复/再生装置,关节软骨修复装置,神经导管,肌腱修复装置,房间隔缺损修复装置,心包块,填充剂和填充剂,静脉瓣,骨髓支架,半月板再生 装置,韧带和腱移植物,眼细胞植入物,脊髓融合笼,皮肤替代物,硬脑膜替代物,骨移植物替代物,骨榫,伤口敷料和止血剂。 聚羟基链烷酸酯可以含有由单体的混合物形成的添加剂,或者在其主链中包括侧基或修饰,或者可以化学改性,以改变降解速率。 聚羟基链烷酸酯组合物还在生理条件下的期望时间范围内提供有利的机械性能,生物相容性和降解时间。
    • 10. 发明申请
    • Polyhydroxyalkanoate compositions having controlled degradation rates
    • 具有受控降解速率的聚羟基链烷酸酯组合物
    • US20030236320A1
    • 2003-12-25
    • US10403942
    • 2003-03-28
    • Metabolix, Inc.
    • David P. MartinFrank SkralySimon F. Williams
    • C08K003/00
    • C08G63/912A61K9/1647A61K47/593A61K47/6957A61L15/26A61L17/10A61L17/12A61L24/0042A61L26/0019A61L26/009A61L27/18A61L27/34A61L27/58A61L29/06A61L31/06A61L31/148C08G63/06C08G63/64C08G63/6852C08G63/6882C08J9/26C08J2201/0444C08J2201/0482C08J2367/04C08K5/0033C12N5/0068C12N2533/30C12P7/625C08L67/04
    • Biocompatible polyhydroxyalkanoate compositions with controlled degradation rates have been developed. In one embodiment, the polyhydroxyalkanoates contain additives to alter the degradation rates. In another embodiment, the polyhydroxyalkanoates are formed of mixtures of monomers or include pendant groups or modifications in their backbones to alter their degradation rates. In still another embodiment, the polyhydroxyalkanoates are chemically modified. Methods for manufacturing the devices which increase porosity or exposed surface area can be used to alter degradability. For example, as demonstrated by the examples, porous polyhydroxyalkanoates can be made using methods that creates pores, voids, or interstitial spacing, such as an emulsion or spray drying technique, or which incorporate leachable or lyophilizable particles within the polymer. Examples describe poly(4HB) compositions including foams, coatings, meshes, and microparticles. As demonstrated by the examples, these polyhydroxyalkanoate compositions have extremely favorable mechanical properties, as well as are biocompatible and degrade within desirable time frames under physioogical conditions. These polyhydroxyalkanoate materials provide a wider range of polyhydroxyalkanoate degradation rates than are currently available. Methods for processing these materials, particularly for therapeutic, prophylactic or diagnostic applications, or into devices which can be implanted or injected, are also described.
    • 已经开发了具有受控降解速率的生物相容性聚羟基链烷酸酯组合物。 在一个实施方案中,聚羟基链烷酸酯含有改变降解速率的添加剂。 在另一个实施方案中,聚羟基链烷酸酯由单体的混合物形成或包括侧链基团或其主链中的修饰以改变其降解速率。 在另一个实施方案中,聚羟基链烷酸酯被化学改性。 用于制造增加孔隙率或暴露表面积的装置的方法可用于改变降解性。 例如,如通过实施例所证明的,多孔聚羟基链烷酸酯可以使用产生孔,空隙或间隙的方法,例如乳液或喷雾干燥技术,或者在聚合物内含有可浸出或可冷冻干燥的颗粒。 实例描述了包括泡沫,涂层,网格和微粒的聚(4HB)组合物。 如实施例所示,这些聚羟基链烷酸酯组合物具有非常有利的机械性能,并且在生理条件下在期望的时间范围内是生物相容的和降解的。 这些聚羟基链烷酸酯材料提供比目前可获得的更广泛的聚羟基链烷酸酯降解速率。 还描述了用于处理这些材料的方法,特别是用于治疗,预防或诊断应用,或可植入或注射的装置。